Novel fragment-based QSAR modeling and combinatorial design of pyrazole-derived CRK3 inhibitors as potent antileishmanials.
about
Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationshipsFragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.Molecular dynamics-based identification of novel natural mortalin-p53 abrogators as anticancer agents.Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation.Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling ApproachIn silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation.
P2860
Q35529563-4DB5D2C7-529C-4D42-B81C-38ED38769D0AQ35652106-42BEE99A-7AAA-489E-87C0-5D231AA92E91Q35824698-7ED4396E-D0A7-4A16-B8CA-DADF90C633A9Q36068317-4C38322F-2DA5-4C5A-8AAB-7557933E8AF8Q36268797-98283898-4EC1-4772-B2FD-987B80173B0EQ37020701-7FC6BDFE-D2D5-4EFC-8775-242C8B524C8EQ41103388-B2D2E1D4-5DE9-4680-8880-22B6548CBD47Q53739072-2F666A6C-F43F-438A-8BF4-F087F46DE9AE
P2860
Novel fragment-based QSAR modeling and combinatorial design of pyrazole-derived CRK3 inhibitors as potent antileishmanials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@en
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@nl
type
label
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@en
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@nl
prefLabel
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@en
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@nl
P2093
P2860
P356
P1476
Novel fragment-based QSAR mode ...... rs as potent antileishmanials.
@en
P2093
Abhinav Grover
Chetna Tyagi
Jaspreet K Dhanjal
Manisha Goyal
Sukriti Goyal
P2860
P356
10.1111/CBDD.12290
P577
2014-05-14T00:00:00Z